$562.02
-3.70-0.65%
Last update: Nov 6, 6:00 PM
United Therapeutics Corp (UTHR) Stock Price, Quote, News & History
UTHRNASDAQ
Liquidia (LQDA) stock jumped 40% after settling all lawsuit battles with United Therapeutics for $380.7M. YUTREPIA PAH sales continue.
You can purchase shares of United Therapeutics (NASDAQ:UTHR) through any online brokerage.
Other companies in United Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
United Therapeutics has a consensus price target of $556.30.
The stock price for United Therapeutics (NASDAQ: UTHR) is $562.02 last updated November 6, 2026 at 6:00 PM EST.
There are no upcoming dividends for United Therapeutics.
United Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for United Therapeutics.
United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...
